Is NCT01701323 results overdue?

Yes — results are overdue. Primary completion was 2018-05-10; the FDAAA-801 reporting deadline (2019-05-10) passed 2645 days ago and no results are posted on ClinicalTrials.gov.

Expanded Cord Blood Cell Infusion Following Combination Chemotherapy in Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT ID	NCT01701323 ↗
Sponsor	Nohla Therapeutics, Inc. (INDUSTRY)
Phase	PHASE1
Status	TERMINATED
Primary completion	2018-05-10 (ACTUAL)
Reporting deadline	2019-05-10 (completion + 365d)
Days overdue	2645
Results posted	No — check results tab ↗
FDA-regulated	drug: yes, device: no
Provenance	Flagged overdue on 2026-06-21 · SHA-256 `565e41e6e4a3a543…` (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT01701323. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.